Article
Protective effect of leflunomide on the natural course of Leishmania major-induced disease in genetically susceptible BALB/c mice.
International journal of immunopharmacology - 1 Jun 1995
Solbach W, Asmuss P A, Zimmermann S, Humborg C, Röllinghoff M
Abstract excerpt
Leflunomide has been reported as an immunomodulating agent which acts on a variety of cells including T- and B-lymphocytes. CD4+ T-lymphocytes are essential for the type of disease that develops after infection with the protozoan parasite Leishmania major. A variety of immunological interventions has been shown to modulate disease development. Therefore, the effect of leflunomide on the development of...
Topics
- Animals
- Antiparasitic Agents
- Antiprotozoal Agents
- Female
- Genetic Predisposition to Disease
- Immunity, Innate
- Isoxazoles
- Leflunomide
- Leishmania major
- Leishmaniasis, Cutaneous
- Mice
